Medistim ASA (STU:MD1) Gross Margin %: 79.56% (As of Mar. 2026) — Near Median


STU:MD1 Medistim ASA STU:MD1
92 GF Score
Price €19.95
GF Value €22.51
! 1 Warning Sign
View Full Analysis

What is Medistim ASA Gross Margin %?

Medistim ASA STU:MD1 92 Gross Margin % is 79.56% as of Mar. 2026, which is 2% above its 10-year median of 77.83. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.51. The stock has 1 warning sign investors should review. Among 804 Medical Devices & Instruments companies, Medistim ASA ranks better than 92.04% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Medistim ASA's Gross Profit for the three months ended in Mar. 2026 was €14.37 Mil. Medistim ASA's Revenue for the three months ended in Mar. 2026 was €18.06 Mil. Therefore, Medistim ASA's Gross Margin % for the quarter that ended in Mar. 2026 was 79.56%.


The historical rank and industry rank for Medistim ASA's Gross Margin % or its related term are showing as below:

STU:MD1' s Gross Margin % Range Over the Past 10 Years
Min: 75.27   Med: 77.83   Max: 81.68
Current: 80.71


During the past 13 years, the highest Gross Margin % of Medistim ASA was 81.68%. The lowest was 75.27%. And the median was 77.83%.

STU:MD1's Gross Margin % is ranked better than
92.04% of 804 companies
in the Medical Devices & Instruments industry
Industry Median: 51.985 vs STU:MD1: 80.71

Medistim ASA had a gross margin of 79.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Medistim ASA was 0.90% per year.


Medistim ASA  (STU:MD1) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medistim ASA had a gross margin of 79.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Medistim ASA Gross Margin % Related Terms


Medistim ASA Gross Margin % Historical Data

* Premium members only.

The historical data trend for Medistim ASA's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Gross Margin % Chart

Medistim ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.76 78.10 78.45 79.79 81.68

Medistim ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.16 81.88 81.51 80.18 79.56

STU:MD1 vs ABT, SYK, MDT: Gross Margin % Comparison

For the Medical Devices subindustry, Medistim ASA's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA Gross Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Gross Margin % falls into.


STU:MD1
92GF Score
Medistim ASA STU:MD1
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistim ASA Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Medistim ASA's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=48.3 / 59.128
=(Revenue - Cost of Goods Sold) / Revenue
=(59.128 - 10.83) / 59.128
=81.68 %

Medistim ASA's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=14.4 / 18.061
=(Revenue - Cost of Goods Sold) / Revenue
=(18.061 - 3.692) / 18.061
=79.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 79.56% mean?
Medistim ASA (STU:MD1) has a Gross Margin % of 79.56% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Medistim ASA and its competitors. This is near median its historical median of 77.83. Over the past decade, Medistim ASA's Gross Margin % has ranged from 75.27 to 81.68. According to the industry distribution chart, Medistim ASA ranks #64 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 8%.
Is Medistim ASA's Gross Margin % too high?
Medistim ASA's current Gross Margin % of 79.56% is near median its 10-year median of 77.83. Over the past 10 years, this metric has ranged from a low of 75.27 to a high of 81.68. The Medical Devices & Instruments industry median Gross Margin % is 51.99. Medistim ASA's value of 79.56% is 53% above this industry median. Based on the distribution chart, Medistim ASA ranks #64 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #64 out of 804 companies for Gross Margin %. This places Medistim ASA in the top 8% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.99. Medistim ASA's value of 79.56% is 53% above this benchmark. Historically, Medistim ASA's own Gross Margin % has ranged from 75.27 to 81.68 over the past decade. While the company's 10-year median is 77.83 vs. the industry median of 51.99, Medistim ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current Gross Margin % of 79.56% is 53% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current Gross Margin % is 79.56%, which is near median its own 10-year median of 77.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current Gross Margin % of 79.56%. The stock's GF Value™ is €22.51, compared to a current price of €19.95 — trading 11.4% below its estimated fair value. The current Gross Margin % is 79.56%, which is near median its 10-year median of 77.83 and 53% above the Medical Devices & Instruments industry median of 51.99. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current Gross Margin % is 79.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (STU:MD1) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of €19.95 is trading 11.4% below its estimated GF Value™ of €22.51.

Key valuation signals for STU:MD1:

  • Gross Margin %: 79.56% (near median its 10-year median of 77.83)
  • GF Value™: €22.51 vs. price of €19.95 (11.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign
  • Industry Position: 53% above the Medical Devices & Instruments median (#64 of 804)

No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score

Get the complete analysis for STU:MD1

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.95
Price
€22.51
GF Value